Prosecution Insights
Last updated: April 19, 2026

Examiner: BARHAM, BETHANY P

Tech Center 1600 • Art Units: 1600 1611 1615

This examiner grants 52% of resolved cases

Performance Statistics

52.0%
Allow Rate
-8.0% vs TC avg
522
Total Applications
+32.3%
Interview Lift
1427
Avg Prosecution Days
Based on 506 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
19.6%
§102 Novelty
42.8%
§103 Obviousness
19.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19175639 INHALABLE POROUS MICROSPHERE LOADED WITH RECOMBINANT HUMAN RELAXIN-2 AND PREPARATION METHOD THEREFOR Final Rejection SHANDONG UNIVERSITY
18246508 PROPHYLACTIC AGENT, AMELIORATING AGENT, AND THERAPEUTIC AGENT FOR DRY EYE Final Rejection TSUBOTA LABORATORY, INC.
18492882 ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF Non-Final OA Arbor Pharmaceuticals, LLC
18188045 GOLD KIWIFRUIT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREFOR Non-Final OA Anagenix IP Limited
17789698 Methotrexate Dosage Form Non-Final OA ROS Therapeutics ApS
17445992 MODIFIED RELEASE FORMULATIONS OF LEVODOPA Final Rejection RUBICON RESEARCH PRIVATE LIMITED
17264019 COMPOSITION OF CARBON DIOXIDE ABSORBENT OR ADSORBENT, WHEREBY THE SAID COMPOSITION CONTAINS A POLYMERIC COATING SELECTED FROM SILICONE RUBBER AND CELLULOSE DERIVATIVE Non-Final OA 011 BIOMEDICAL GMBH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month